AWM
ATRS

AE Wealth Management’s Antares Pharma, Inc. ATRS Stock Holding History

AE Wealth Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-20,766
Closed -$83K – 1598
2020
Q4 		$83K Buy
20,766
+500
+2% +$1.62K ﹤0.01% 1317
2020
Q3 		$55K Hold
20,266
– – ﹤0.01% 1234
2020
Q2 		$56K Sell
20,266
-4,520
-18% -$12.6K ﹤0.01% 1216
2020
Q1 		$58K Sell
24,786
-28
-0.1% -$95 ﹤0.01% 1062
2019
Q4 		$117K Sell
24,814
-7,169
-22% -$29.3K ﹤0.01% 1086
2019
Q3 		$107K Buy
31,983
+2,333
+8% +$7.68K ﹤0.01% 950
2019
Q2 		$98K Buy
+29,650
New +$85.8K ﹤0.01% 931

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

AE Wealth Management's ATRS Position: Q1 2021 in Review

AE Wealth Management sold out of Antares Pharma, Inc. (ATRS) in Q1 2021, closing a stake of 20,766 shares — an estimated $83K sold.

AE Wealth Management first reported a position in ATRS in Q2 2019 and held it in 7 quarters. The position peaked at $117K in Q4 2019. 171 funds tracked by Wall St. Rank hold ATRS as of Q1 2021.

  • AE Wealth Management reported no remaining Antares Pharma, Inc. position as of Q1 2021 after selling out during the quarter.
  • AE Wealth Management sold 20,766 Antares Pharma, Inc. shares in Q1 2021, an estimated $83K.
  • AE Wealth Management first reported a position in Antares Pharma, Inc. in Q2 2019 and held it in 7 quarters.
  • AE Wealth Management's Antares Pharma, Inc. position peaked at $117K in Q4 2019.
  • 171 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2021.

Based on AE Wealth Management's 13F filing for Q1 2021, filed 27 Apr 2021.